Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Total revenue, net	$ 2,134	$ 4,812
Operating expenses:
Cost of product sold	41	8,391
Research and development	40,694	70,831
Selling, general and administrative	28,214	40,729
Total operating expenses	68,949	119,951
Loss from operations	(66,815)	(115,139)
Other income	4,808	2,127
Net loss and comprehensive loss	$ (62,007)	$ (113,012)
Net loss per share - basic	$ (34.12)	$ (62.77)
Net loss per share - diluted	$ (34.12)	$ (62.77)
Weighted average shares used in the calculation of net loss per share, basic	1,817,506	1,800,447
Weighted average shares used in the calculation of net loss per share, diluted	1,817,506	1,800,447
Grant
Revenue	$ 1,722	$ 1,160
Product revenue, net
Revenue	$ 412	$ 3,652